2026.Jul.06

Award & Certification​

OBI Pharma’s Obrion® ADC Technology Platform Wins Product Innovation of the Year at the 2026 Taiwan BIO Awards

Taiwan-Originated ADC Platform Recognized for Innovation, Commercialization Potential, and Global Market Advancement

HOMEWhat’s NewNewsOBI Pharma’s Obrion® ADC Technology Platform Wins Product Innovation of the Year at the 2026 Taiwan BIO Awards

Back to List

This article is password protected.

To view the content, please enter your password in the field below

2026.Jun.26

OBI Holds 2026 Annual Shareholders’ Meeting Capturing Global Opportunities in Next-Generation ADCs with Its Proprietary Obrion® Platform to Advance Bispecific Dual-Payload ADCs and International Licensing Strategy